Zhuhai-based Livzon Pharmaceutical Group Inc. (Livzon Pharma) released an update on 24 March 2026 outlining the composition of its Board of Directors and five specialised board committees.

The Board now consists of nine members: • Executive Director – Tang Yanggang (Vice Chairman) • Non-executive Directors – Zhu Baoguo (Chairman), Lin Nanqi, Qiu Qingfeng • Employee Representative Director – Ran Yongmei • Independent Non-executive Directors – Bai Hua, Luo Huiyuan, Cui Lijie, Wang Zhiyao

Committee structure and key roles 1. Five committees are in place: Audit; Remuneration and Assessment; Nomination; Strategy; and Environmental, Social and Governance (ESG). 2. Chairmanships are distributed among four directors: – Zhu Baoguo heads two committees. – Bai Hua, Luo Huiyuan and Cui Lijie each chair one committee. 3. Executive Director Tang Yanggang serves as a member of four committees, providing operational representation across most governance functions. 4. All independent non-executive directors participate in at least one committee, in line with corporate governance best practices.

The updated structure is designed to strengthen oversight in key areas—financial reporting, remuneration, strategic planning and ESG—while maintaining a balanced mix of executive, non-executive and independent perspectives on the Board.